{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:08Z","timestamp":1787003648731,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102871"],"award-info":[{"award-number":["82102871"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prostate cancer (PCa) ranks among the most prevalent malignant tumors worldwide. The pivotal role of competitive endogenous RNA (ceRNA) regulatory networks in numerous cancer types has been underscored. However, the specific characteristics of the ceRNA network in PCa remained unknown. This study aims to elucidate the ceRNA regulatory network associated with phosphatase and tensin homolog (PTEN) and to identify potential prognostic markers for PCa. The Cancer Genome Atlas (TCGA) database was employed to extract the expression patterns of long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs). LINC01122-hsa-miR-34c-5p\/hsa-miR-449a-TPD52 ceRNA network regarding the prognosis of PCa was explored via bioinformatics analysis. Through correlation analysis, we investigated the LINC01122\/TPD52 axis within the ceRNA network, identifying it as a significant clinical prognostic marker for PCa. Subsequent analyses indicated that hypomethylation was responsible for the abnormal upregulation of the LINC01122\/TPD52 axis. Furthermore, immune infiltration analysis revealed the impact of the LINC01122\/TPD52 axis on the tumor immune microenvironment and the progression of PCa. Finally, a nomogram was constructed to forecast the 1-year, 3-year, and 5-year survival probabilities of PCa patients. In summary, our study demonstrates the significant role of the ceRNA-based LINC01122\/TPD52 axis in the progression of PCa and its correlation with prognosis.<\/jats:p>","DOI":"10.1038\/s41598-025-98219-1","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T11:30:41Z","timestamp":1746703841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive analysis of the LINC01122\/TPD52 axis as a predictive biomarker in prostate adenocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhi","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"3","key":"98219_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"98219_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s44178-024-00118-4","volume":"3","author":"B Dai","year":"2024","unstructured":"Dai, B. et al. CACA guidelines for holistic integrative management of prostate cancer. Holist. Integ. Oncol. 3 (1), 47 (2024).","journal-title":"Holist. Integ. Oncol."},{"issue":"1","key":"98219_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello, R. J. et al. Prostate cancer. Nat. Rev. Dis. Primers. 7 (1), 9 (2021).","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"12","key":"98219_CR4","doi-asserted-by":"publisher","first-page":"e1672494","DOI":"10.1080\/2162402X.2019.1672494","volume":"8","author":"S Yunger","year":"2019","unstructured":"Yunger, S. et al. Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy. Oncoimmunology 8 (12), e1672494 (2019).","journal-title":"Oncoimmunology"},{"issue":"2","key":"98219_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cell.2018.03.059","volume":"173","author":"A Blum","year":"2018","unstructured":"Blum, A. & Wang, P. Zenklusen JC. SnapShot: TCGA-Analyzed tumors. Cell 173 (2), 530 (2018).","journal-title":"Cell"},{"issue":"3","key":"98219_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp, F. & Mendell, J. T. Functional classification and experimental dissection of long noncoding RNAs. Cell 172 (3), 393\u2013407 (2018).","journal-title":"Cell"},{"issue":"1","key":"98219_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s13402-014-0180-x","volume":"38","author":"M Vitiello","year":"2015","unstructured":"Vitiello, M., Tuccoli, A. & Poliseno, L. Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol. (Dordr.) 38 (1), 17\u201328 (2015).","journal-title":"Cell Oncol. (Dordr.)"},{"issue":"15","key":"98219_CR8","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan, A., Soleimani, M. & Mandal, S. S. Long noncoding RNA and cancer: A new paradigm. Cancer Res. 77 (15), 3965\u20133981 (2017).","journal-title":"Cancer Res."},{"issue":"4","key":"98219_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu, T. X. & Rothenberg, M. E. MicroRNA. J. Allergy Clin. Immunol. 141 (4), 1202\u20131207 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"98219_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41392-019-0080-7","volume":"4","author":"Y Li","year":"2019","unstructured":"Li, Y., Yin, Z., Fan, J., Zhang, S. & Yang, W. The roles of exosomal miRNAs and lncRNAs in lung diseases. Signal Transduct. Target. Ther. 4, 47 (2019).","journal-title":"Signal Transduct. Target. Ther."},{"key":"98219_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","volume":"4","author":"YS Lee","year":"2009","unstructured":"Lee, Y. S. & Dutta, A. MicroRNAs in cancer. Annu. Rev. Pathol. 4, 199\u2013227 (2009).","journal-title":"Annu. Rev. Pathol."},{"issue":"3","key":"98219_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: the rosetta stone of a hidden RNA language?. Cell 146 (3), 353\u2013358 (2011).","journal-title":"Cell"},{"issue":"8","key":"98219_CR13","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1158\/0008-5472.CAN-16-3236","volume":"77","author":"M Rokavec","year":"2017","unstructured":"Rokavec, M., Horst, D. & Hermeking, H. Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs, and epigenetic modifications associated with metastasis. Cancer Res. 77 (8), 1854\u20131867 (2017).","journal-title":"Cancer Res."},{"key":"98219_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.semcancer.2019.02.001","volume":"59","author":"V Alvarez-Garcia","year":"2019","unstructured":"Alvarez-Garcia, V., Tawil, Y., Wise, H. M. & Leslie, N. R. Mechanisms of PTEN loss in cancer: It\u2019s all about diversity. Semin. Cancer Biol. 59, 66\u201379 (2019).","journal-title":"Semin. Cancer Biol."},{"key":"98219_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1146\/annurev-biochem-082411-113907","volume":"83","author":"CA Worby","year":"2014","unstructured":"Worby, C. A. & Dixon, J. E. PTEN. Annu. Rev. Biochem. 83, 641\u2013669 (2014).","journal-title":"Annu. Rev. Biochem."},{"key":"98219_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-052218-125823","volume":"71","author":"L Yehia","year":"2020","unstructured":"Yehia, L., Keel, E. & Eng, C. The clinical spectrum of PTEN mutations. Annu Rev Med. 71, 103\u2013116 (2020).","journal-title":"Annu Rev Med."},{"issue":"3","key":"98219_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/CS20160026","volume":"131","author":"HM Wise","year":"2017","unstructured":"Wise, H. M., Hermida, M. A. & Leslie, N. R. Prostate cancer, PI3K, PTEN and prognosis. Clin. Sci. (Lond.) 131 (3), 197\u2013210 (2017).","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"98219_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"21","key":"98219_CR19","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","volume":"30","author":"F Azimi","year":"2012","unstructured":"Azimi, F. et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J. Clin. Oncol. 30 (21), 2678\u20132683 (2012).","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"98219_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","volume":"11","author":"AJ Chang","year":"2014","unstructured":"Chang, A. J., Autio, K. A., Roach, M. 3rd. & Scher, H. I. High-risk prostate cancer-classification and therapy. Nat. Rev. Clin. Oncol. 11 (6), 308\u2013323 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"98219_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","volume":"70","author":"MY Teo","year":"2019","unstructured":"Teo, M. Y., Rathkopf, D. E. & Kantoff, P. Treatment of advanced prostate cancer. Annu. Rev. Med. 70, 479\u2013499 (2019).","journal-title":"Annu. Rev. Med."},{"issue":"S1","key":"98219_CR22","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1038\/modpathol.2017.158","volume":"31","author":"AJ Evans","year":"2018","unstructured":"Evans, A. J. Treatment effects in prostate cancer. Mod. Pathol. 31 (S1), S110\u2013S121 (2018).","journal-title":"Mod. Pathol."},{"issue":"7483","key":"98219_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay, Y., Rinn, J. & Pandolfi, P. P. The multilayered complexity of ceRNA crosstalk and competition. Nature 505 (7483), 344\u2013352 (2014).","journal-title":"Nature"},{"key":"98219_CR24","doi-asserted-by":"publisher","first-page":"921194","DOI":"10.3389\/fonc.2022.921194","volume":"12","author":"X Qi","year":"2022","unstructured":"Qi, X. et al. Prognostic roles of ceRNA network-based signatures in gastrointestinal cancers. Front. Oncol. 12, 921194 (2022).","journal-title":"Front. Oncol."},{"key":"98219_CR25","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.omtn.2020.12.016","volume":"23","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Comprehensive analysis to identify DLEU2L\/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma. Mol. Ther. Nucleic Acids 23, 702\u2013718 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"22","key":"98219_CR26","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.3390\/ijms21228855","volume":"21","author":"EA Braga","year":"2020","unstructured":"Braga, E. A. et al. LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms. Int. J. Mol. Sci. 21 (22), 8855 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"98219_CR27","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.3390\/ijms20225758","volume":"20","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Long noncoding RNA (lncRNA)-mediated competing endogenous rna networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int. J. Mol. Sci. 20 (22), 5758 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"98219_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41392-020-0196-9","volume":"5","author":"L Chen","year":"2020","unstructured":"Chen, L., Liu, S. & Tao, Y. Regulating tumor suppressor genes: post-translational modifications. Signal Transduct. Target. Ther. 5 (1), 90 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"98219_CR29","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/2159-8290.CD-19-1352","volume":"10","author":"D Zhao","year":"2020","unstructured":"Zhao, D. et al. Chromatin regulator CHD1 remodels the immunosuppressive tumor microenvironment in PTEN-deficient prostate cancer. Cancer Discov. 10 (9), 1374\u20131387 (2020).","journal-title":"Cancer Discov."},{"key":"98219_CR30","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.2147\/OTT.S324015","volume":"14","author":"Z Shen","year":"2021","unstructured":"Shen, Z. & Sun, S. CircPTCH1 promotes migration in lung cancer by regulating MYCN expression through miR-34c-5p. Onco Targ. Ther. 14, 4779\u20134789 (2021).","journal-title":"Onco Targ. Ther."},{"issue":"5","key":"98219_CR31","first-page":"1515","volume":"52","author":"N Li","year":"2018","unstructured":"Li, N. et al. Downregulation of SIRT6 by miR-34c-5p is associated with poor prognosis and promotes colon cancer proliferation through inhibiting apoptosis via the JAK2\/STAT3 signaling pathway. Int. J. Oncol. 52 (5), 1515\u20131527 (2018).","journal-title":"Int. J. Oncol."},{"key":"98219_CR32","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11759","author":"H Wei","year":"2021","unstructured":"Wei, H. et al. miR-34c-5p targets Notch1 and suppresses the metastasis and invasion of cervical cancer. Mol. Med. Rep. https:\/\/doi.org\/10.3892\/mmr.2020.11759 (2021).","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"98219_CR33","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/CAD.0000000000000555","volume":"28","author":"H Yong-Ming","year":"2017","unstructured":"Yong-Ming, H. et al. miR-449a: a potential therapeutic agent for cancer. Anticancer Drugs 28 (10), 1067\u20131078 (2017).","journal-title":"Anticancer Drugs"},{"issue":"11","key":"98219_CR34","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1158\/0008-5472.CAN-03-3881","volume":"64","author":"MA Rubin","year":"2004","unstructured":"Rubin, M. A. et al. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res. 64 (11), 3814\u20133822 (2004).","journal-title":"Cancer Res."},{"issue":"7","key":"98219_CR35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","volume":"38","author":"AL Mattei","year":"2022","unstructured":"Mattei, A. L., Bailly, N. & Meissner, A. DNA methylation: a historical perspective. Trends Genet. 38 (7), 676\u2013707 (2022).","journal-title":"Trends Genet."},{"issue":"7","key":"98219_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41571-018-0004-4","volume":"15","author":"A Koch","year":"2018","unstructured":"Koch, A. et al. Analysis of DNA methylation in cancer: location revisited. Nat. Rev. Clin. Oncol. 15 (7), 459\u2013466 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"98219_CR37","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ymthe.2020.10.027","volume":"29","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. Reshaping the immune microenvironment by oncolytic herpes simplex virus in murine pancreatic ductal adenocarcinoma. Mol. Ther. 29 (2), 744\u2013761 (2021).","journal-title":"Mol. Ther."},{"key":"98219_CR38","doi-asserted-by":"publisher","first-page":"730746","DOI":"10.3389\/fimmu.2021.730746","volume":"12","author":"S Pineda","year":"2021","unstructured":"Pineda, S. et al. Tumor-infiltrating B- and T-Cell repertoire in pancreatic cancer associated with host and tumor features. Front. Immunol. 12, 730746 (2021).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98219-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98219-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98219-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T11:30:42Z","timestamp":1746703842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98219-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98219"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98219-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16122"}}